Wockhardt Slides To Loss Amid US Oncology Push

 
• By Aidan Fry
  
RandD
Increased research and development investment, coupled with the costs of remediating quality issues at its facilities, contributed to Wockhardt posting a pre-tax loss • Source: Shutterstock

More from Earnings

More from Business